Immunomodulation, Bioavailability and Safety of Bacteriocins

Area of Science:

• Microbiology
• Immunology
• Pharmacology

Background:

• Antibiotic resistance and emerging pathogens necessitate novel therapeutic strategies.
• Bacteriocins, bacterial antimicrobial peptides, offer a promising alternative for infectious disease treatment.
• Current applications are primarily in the food industry, but medical potential is growing.

Purpose of the Study:

• To review scientific literature on the immunomodulatory activity, bioavailability, and safety of bacteriocins.
• To assess the potential of bacteriocins for medical applications, particularly in managing inflammation.
• To inform future preclinical and clinical studies on bacteriocin-based therapies.

Main Methods:

• Literature review of studies on bacteriocin immunomodulatory effects in animal models and human cells.
• Analysis of research on bacteriocin bioavailability and safety profiles.
• Synthesis of data regarding bacteriocin's impact on innate and acquired immunity.

Main Results:

• Bacteriocins can induce both pro-inflammatory and anti-inflammatory responses, influencing innate immunity.
• They affect acquired immunity by increasing T-lymphocytes and decreasing B-lymphocytes.
• Bacteriocins demonstrate low toxicity and broad/narrow specificity, with established food industry use.

Conclusions:

• Bacteriocins possess significant immunomodulatory properties relevant for treating various pathologies, especially inflammatory conditions.
• Their safety profile and existing applications support further investigation for medical use.
• The reviewed data provides a foundation for organizing preclinical and clinical trials.